Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 23

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 8
Chunk 23
---
ation preference.

 F-21Table of Contents

Stock Options A summary of the Company’s stock options activity is as follows:   Number of Options   Weighted-Average Exercise Price  Weighted-Average Contractual Term(in years)  Aggregate Intrinsic Value Outstanding at June 30, 2024  21,250,000  $0.12   1.11    Granted  -            Exercised  -   -        Canceled  (21,250,000 )  -        Outstanding at March 31, 2025  -          $- Exercisable at March 31, 2025  -          $-  Significant inputs and results arising from the Black-Scholes process are as follows for the options: Quoted market price on valuation date $0.169 - $0.23 Exercise prices $0.12 Range of expected term 1.55 Years – 2.49 Years Range of market volatility:    Range of equivalent volatility 181.21% - 275.73% Range of interest rates 0.20% - 1.08%  Warrants As of March 31, 2025, and June 30, 2024, the Company had 103,668,828 and 120,497,013 warrants outstanding. The warrants have a term of two to five years, and an exercise price range from $0.021 and $0.1187. The Company evaluated the warrants under ASC 815, Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values. As of March 31, 2025, the weighted average remaining useful life of the warrants was 2.07. The warrants are detailed as follows:  Number of Warrants Number of Warrants  Weighted-AverageExercisePrice  Weighted-AverageContractualTerm(in years)  AggregateIntrinsicValue Outstanding at June 30, 2024  120,497,013  $0.09   2.50  $- Granted  -             Exercised  (1,528,185 )            Canceled  (15